OPKO HEALTH,INC. (OPK)
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General